Pardes Biosciences (NASDAQ:PRDS) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.50) by 18 percent. This is a 26.79 percent increase over losses of $(0.56) per share from the same period last year.
Duck Creek Technologies Q4 Adj. EPS $0.03 Beats $0.02 Estimate, Sales $80.71M Beat $73.36M Estimate
Duck Creek Technologies (NASDAQ:DCT) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.02 by 50 percent. This is a 50 percent increase over earnings of $0.02 per share from
